Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Aurobindo Phar Aurobindo Pharma Ltd. | BSE 1167.20 -5.10 (-0.44%) | NSE 1167.60 -5.10 (-0.43%) | Trade | Add

BSE Live

Jan 19, 16:01

1167.20 -5.10 (-0.44%)

Volume

AVERAGE VOLUME

5-Day

13,390

10-Day

25,681

30-Day

23,411

8,034

NSE Live

Jan 19, 15:49

1167.60 -5.10 (-0.43%)

Volume

AVERAGE VOLUME

5-Day

813,691

10-Day

1,031,550

30-Day

808,943

546,679

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Aurobindo Pharma (in Rs. Cr.)	Mar 05	Mar 04
Per Share Ratios
Basic EPS (Rs.)	6.91	25.02
Diluted EPS (Rs.)	6.91	25.02
Cash EPS (Rs.)	14.88	31.75
Book Value [ExclRevalReserve]/Share (Rs.)	155.30	149.01
Book Value [InclRevalReserve]/Share (Rs.)	155.30	149.01
Dividend / Share(Rs.)	0.50	2.25
Revenue from Operations/Share (Rs.)	213.68	247.01
PBDIT/Share (Rs.)	23.15	46.02
PBIT/Share (Rs.)	15.17	39.29
PBT/Share (Rs.)	8.11	34.12
Net Profit/Share (Rs.)	6.91	25.02
Profitability Ratios
PBDIT Margin (%)	10.83	18.63
PBIT Margin (%)	7.10	15.90
PBT Margin (%)	3.79	13.81
Net Profit Margin (%)	3.23	10.13
Return on Networth / Equity (%)	4.44	16.79
Return on Capital Employed (%)	5.77	16.61
Return on Assets (%)	1.81	7.72
Total Debt/Equity (X)	1.05	0.82
Asset Turnover Ratio (%)	0.61	0.00
Liquidity Ratios
Current Ratio (X)	1.65	2.04
Quick Ratio (X)	1.11	1.45
Inventory Turnover Ratio (X)	2.64	0.00
Dividend Payout Ratio (NP) (%)	7.24	8.99
Dividend Payout Ratio (CP) (%)	3.36	7.08
Earnings Retention Ratio (%)	92.76	91.01
Cash Earnings Retention Ratio (%)	96.64	92.92
Valuation Ratios
Enterprise Value (Cr.)	2,273.47	2,494.63
EV/Net Operating Revenue (X)	2.10	1.99
EV/EBITDA (X)	19.34	10.68
MarketCap/Net Operating Revenue (X)	1.34	1.53
Retention Ratios (%)	92.75	91.00
Price/BV (X)	1.85	2.53
Price/Net Operating Revenue	1.34	1.53
Earnings Yield	0.02	0.07